Safety Topics
Side-effect and safety topics — each article grounded in published trial data.
Find the evidence for a specific concern. Rates depend on the drug, study, dose and population; a class-wide percentage cannot describe your individual risk.
Choose a safety topic
Side effects and study rates →
Read adverse events by trial and dose, with their limitations.
Lean mass and strength →
Understand what body-composition scans measure and what they leave unanswered.
Hair changes →
Review the evidence and other possible contributors to hair loss.
Drug interactions and clearance →
See the pharmacokinetic data and unresolved interaction questions.
Unverified products →
Understand product identity, quality and contamination concerns.
Food and low appetite →
Find nutrition guidance and questions to discuss when intake is difficult.
These pages explain research. For symptoms or treatment decisions, contact the clinician responsible for your care.
Browse safety
8 articles
Does Retatrutide Cause Muscle Loss?
The DXA substudy measured fat and lean-mass reductions. It does not prove a muscle-sparing effect or establish outcomes for every patient.
Updated October 2, 2026
GLP-1 Drugs and Mental Health: What the Evidence Actually Shows
Reassuring psychiatric safety findings, trial exclusions and what remains unknown about retatrutide and anhedonia.
Updated September 8, 2026
Grey Market Retatrutide: Risks, Dangers, and What You Should Know
Research labels and purity claims do not establish product equivalence, approved dosing or legal exemptions.
Updated September 8, 2026
How to Reconstitute Retatrutide (and Why You Shouldn't)
Concentration math cannot establish vial identity, sterility or stability. Trial participants need product-specific study instructions.
Updated September 8, 2026
Retatrutide (GLP-3) Side Effects & Safety Data (2026)
Separate trial tables for retatrutide GI effects and dysesthesia, with rare-event findings and current safety uncertainties.
Updated September 8, 2026
Retatrutide and Alcohol: What We Know
Semaglutide alcohol-use trials are promising but do not establish safe drinking or liver protection with retatrutide.
Updated September 8, 2026
Retatrutide and Hair Loss: What the Evidence Shows
Hair shedding, drug effects and weight loss are not interchangeable. What is known, and what retatrutide data cannot yet establish.
Updated September 8, 2026
Retatrutide and Pregnancy: Safety, Contraception and Planning
No validated retatrutide pregnancy washout exists. What human observations, animal models and other product labels can tell us.
Updated September 8, 2026